Marı́a Rozman
Impact in
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Chronic Myeloid Leukemia Treatments
Papers in
- Genetics 67
- Chronic Lymphocytic Leukemia Research 42
- Myeloproliferative Neoplasms: Diagnosis and Treatment 22
- Hematology 67
- Acute Myeloid Leukemia Research 35
- Multiple Myeloma Research and Treatments 25
- Chronic Myeloid Leukemia Treatments 14
- Co-authors
- Emili MontserratElı́as CampoNeus VillamorDolors ColomerFrancesc BoschArmando López‐GuillermoMarta CrespoSílvia Marcé
- Journals
- British Journal of Haematology (14 papers)Blood (11 papers)Annals of Hematology (7 papers)Leukemia (6 papers)Haematologica (5 papers)
- Partner nations
- SpainUnited StatesFrance
In The Last Decade
Marı́a Rozman
116 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Genetics 2.1k
- Hematology 1.4k
- Pathology and Forensic Medicine 1.6k
- Immunology 910
- Oncology 631
Countries citing papers authored by Marı́a Rozman
This map shows the geographic impact of Marı́a Rozman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marı́a Rozman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marı́a Rozman more than expected).
Fields of papers citing papers by Marı́a Rozman
This network shows the impact of papers produced by Marı́a Rozman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marı́a Rozman. The network helps show where Marı́a Rozman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marı́a Rozman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 3 | |
| 5 | 2022 | 9 | |
| 6 | 2022 | 13 | |
| 7 | 2019 | 10 | |
| 8 | 2014 | 9 | |
| 9 | 2013 | 3 | |
| 10 | 2012 | 44 | |
| 11 | 2011 | 2 | |
| 12 | 2009 | 79 | |
| 13 | 2007 | 69 | |
| 14 | 2006 | 91 | |
| 15 | 2002 | 13 | |
| 16 | 2000 | 41 | |
| 17 | 1999 | 24 | |
| 18 | 1995 | 11 | |
| 19 | 1992 | 2 | |
| 20 | Therapy of sheep dicrpcoeliasis, I. Hetolin and Thibenzole. | 1971 | 1 |
About Marı́a Rozman
Marı́a Rozman is a scholar working on Genetics, Hematology, Pathology and Forensic Medicine, Immunology and Emergency Medicine, having authored 128 papers that have together received 3.6k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (42 papers), Acute Myeloid Leukemia Research (35 papers), Lymphoma Diagnosis and Treatment (30 papers), Multiple Myeloma Research and Treatments (25 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (22 papers), Chronic Myeloid Leukemia Treatments (14 papers), Immunodeficiency and Autoimmune Disorders (12 papers) and Hematological disorders and diagnostics (9 papers). The work is most often cited by research in Genetics (2.1k citations), Hematology (1.4k citations), Pathology and Forensic Medicine (1.6k citations), Immunology (910 citations) and Oncology (631 citations). Marı́a Rozman has collaborated with scholars based in Spain, United States and France. Frequent co-authors include Emili Montserrat, Elı́as Campo, Neus Villamor, Dolors Colomer, Francesc Bosch, Armando López‐Guillermo, Marta Crespo, Sílvia Marcé, Beatríz Bellosillo and Jordi Esteve. Their work appears in journals such as British Journal of Haematology, Blood, Annals of Hematology, Leukemia and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.